Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain Tumors

Despite advances in systemic therapies for solid tumors, the development of brain metastases remains a significant contributor to overall cancer mortality and requires improved methods for diagnosing and treating these lesions. Similarly, the prognosis for malignant primary brain tumors remains poor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramkissoon, Lori A., Pegram, Worthy, Haberberger, James, Danziger, Natalie, Lesser, Glenn, Strowd, Roy, Dahiya, Sonika, Cummings, Thomas J., Bi, Wenya Linda, Abedalthagafi, Malak, Sathyan, Pratheesh, McGregor, Kimberly, Reddy, Prasanth, Severson, Eric, Williams, Erik, Lin, Douglas, Edgerly, Claire, Huang, Richard S. P., Hemmerich, Amanda, Creeden, James, Brown, Charlotte, Venstrom, Jeffrey, Hegde, Priti, Ross, Jeffrey S., Alexander, Brian M., Elvin, Julia, Ramkissoon, Shakti H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604477/
https://www.ncbi.nlm.nih.gov/pubmed/33192972
http://dx.doi.org/10.3389/fneur.2020.544680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604477/
https://www.ncbi.nlm.nih.gov/pubmed/33192972
http://dx.doi.org/10.3389/fneur.2020.544680

Ejemplares similares